Nuclear Medicine: Page 85

SNMMI to watch for job-related health problems

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the SNMMI Technologist Section are monitoring potential job-related health risks among its members from occupational exposure to radiation.

February 7, 2018

FDA, NRC clear path for U.S. supply of molybdenum-99

By Erik L. Ridley

A U.S.-based supply of molybdenum-99 is finally at hand: The U.S. Food and Drug Administration (FDA) has approved NorthStar Medical Radioisotopes' RadioGenix isotope separation system, and the U.S. Nuclear Regulatory Commission (NRC) will license the system's production of technetium-99m for medical use.

February 7, 2018

Study tracks radiation dose to NM technologists

By Brian Casey

A new study published February 1 in Radiology on occupational radiation exposure for nuclear medicine (NM) technologists is serving up some intriguing findings. While radiation exposure is generally low and within established guidelines, it has been rising in recent years as the field adopts more powerful imaging technologies.

February 7, 2018

Siemens to sell Symbia Intevo Bold SPECT/CT in Canada

By AuntMinnie.com staff writers

Siemens Healthineers has received regulatory approval to market its Symbia Intevo Bold SPECT/CT system in Canada.

February 7, 2018

ImaginAb appoints new COO

By AuntMinnie.com staff writers

Imaging agent developer ImaginAb appointed Ian Wilson as its new chief operating officer (COO).

February 5, 2018

Flortaucipir-PET could lead in early Alzheimer's detection

By Wayne Forrest

PET scans with the novel radiotracer flortaucipir may provide more valuable information in the early detection of neurodegeneration associated with Alzheimer's disease than MRI, according to a study published in the February issue of the Journal of Nuclear Medicine.

February 5, 2018

Philips closes purchase of Digirad service contracts

By AuntMinnie.com staff writers

Nuclear medicine firm Digirad has sold its Medical Device Sales and Service (MDSS) business unit service contracts to Philips Healthcare for $8 million.

February 4, 2018

PSMA-PET/CT helps spot early prostate cancer recurrence

By Wayne Forrest

PET/CT imaging with gallium-68 prostate-specific membrane antigen (PSMA-11) could help in the early detection and treatment of recurrent prostate cancer after a patient undergoes radical prostatectomy, according to a study in the February issue of the Journal of Nuclear Medicine.

February 1, 2018

FDA approves new radionuclide therapy by AAA

By AuntMinnie.com staff writers

French molecular imaging firm Advanced Accelerator Applications (AAA) said the U.S. Food and Drug Administration (FDA) has approved a new drug application for its Lutathera radiopharmaceutical.

January 28, 2018

Nuclear medicine techs have higher risk of cataracts

By Kate Madden Yee

Technologists who perform nuclear medicine exams, either diagnostic or therapeutic, have an increased risk of developing cataracts, according to a study published in the February issue of Radiology.

January 25, 2018

Curium switches Mo-99 production process to LEU

By AuntMinnie.com staff writers

The U.S. Department of Energy's National Nuclear Security Administration and global healthcare company Curium have reached a milestone in their effort to manufacture molybdenum-99 (Mo-99) in the U.S.

January 24, 2018

FDG-PET/CT predicts outcomes in pediatric osteosarcoma

By Wayne Forrest

The best way to predict a good outcome for pediatric patients with osteosarcoma is by performing FDG-PET/CT scans at regular intervals in the first several months after the start of chemotherapy, according to a study published in the January issue of the Journal of Nuclear Medicine.

January 18, 2018

Previous Page

Page 85 of 440

Next Page